Cargando…

Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial

BACKGROUND: Despite the high prevalence of insomnia in patients with advanced cancer, there are no randomized controlled trials on pharmacological interventions for insomnia in this group of patients. A variety of pharmacological agents is recommended to manage sleep disturbance for insomnia in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jakobsen, Gunnhild, Engstrøm, Morten, Paulsen, Ørnulf, Sjue, Karin, Raj, Sunil X., Thronæs, Morten, Hjermstad, Marianne Jensen, Kaasa, Stein, Fayers, Peter, Klepstad, Pål
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307135/ https://www.ncbi.nlm.nih.gov/pubmed/30591073 http://dx.doi.org/10.1186/s13063-018-3088-3

Ejemplares similares

Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer—a double-blind, randomized placebo-controlled clinical multicenter phase IV trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2022)

The short-term impact of methylprednisolone on patient-reported sleep in patients with advanced cancer in a randomized, placebo-controlled, double-blind trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2020)

The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer
por: Paulsen, Ørnulf, et al.
Publicado: (2017)

Antibiotic Therapy in Integrated Oncology and Palliative Cancer Care: An Observational Study
por: Moen, Martine Kjølberg, et al.
Publicado: (2022)

An Update on Prevalence, Assessment, and Risk Factors for Sleep Disturbances in Patients with Advanced Cancer—Implications for Health Care Providers and Clinical Research
por: Jakobsen, Gunnhild, et al.
Publicado: (2022)

Emergency Palliative Cancer Care: Dexmedetomidine Treatment Experiences—A Retrospective Brief Report on Nine Consecutive Cases
por: Løhre, Erik Torbjørn, et al.
Publicado: (2023)

Eszopiclone versus zopiclone in the treatment of insomnia
por: Pinto, Luciano Ribeiro, et al.
Publicado: (2016)

Inadequate symptom control in advanced cancer patients across Europe
por: Laugsand, Eivor A., et al.
Publicado: (2010)

Pain Intensity Factors Changing Breakthrough Pain Prevalence in Patients with Advanced Cancer: A Secondary Analysis of a Cross-Sectional Observational International Study
por: Løhre, Erik Torbjørn, et al.
Publicado: (2018)

Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study
por: Leufkens, T. R. M., et al.
Publicado: (2014)

An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer
por: Dolan, Ross D., et al.
Publicado: (2019)

Parenteral Formulation of Zopiclone
por: Swamy, P. V., et al.
Publicado: (2008)

Interventions and symptom relief in hospital palliative cancer care: results from a prospective longitudinal study
por: Thronæs, Morten, et al.
Publicado: (2021)

P018 The effects of zopiclone on sleep spindles in obstructive sleep apnea: A randomized placebo-controlled trial
por: Carter, S, et al.
Publicado: (2021)

Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids
por: Laugsand, Eivor A, et al.
Publicado: (2015)

Doloplus-2, a valid tool for behavioural pain assessment?
por: Hølen, Jacob C, et al.
Publicado: (2007)

Benefits of Study Participation for Patients with Advanced Cancer Receiving Radiotherapy: A Prospective Observational Study
por: Bye, Asta, et al.
Publicado: (2022)

Integration of palliative care in oncology—the intersection of cultures and perspectives of oncology and palliative care
por: Lundeby, Tonje, et al.
Publicado: (2022)

Barriers to and facilitators for implementing quality improvements in palliative care – results from a qualitative interview study in Norway
por: Sommerbakk, Ragni, et al.
Publicado: (2016)

Can cancer patients assess the influence of pain on functions? A randomised, controlled study of the pain interference items in the Brief Pain Inventory
por: Stenseth, Guri, et al.
Publicado: (2007)

Reversal of a Suspected Paradoxical Reaction to Zopiclone with Flumazenil
por: Jordahn, Zarah, et al.
Publicado: (2016)

Fully Integrated Oncology and Palliative Care Services at a Local Hospital in Mid-Norway: Development and Operation of an Innovative Care Delivery Model
por: Brenne, Anne-Tove, et al.
Publicado: (2020)

Is there a genetic cause of appetite loss?—an explorative study in 1,853 cancer patients
por: Solheim, Tora S., et al.
Publicado: (2012)

The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis
por: Vagnildhaug, Ola Magne, et al.
Publicado: (2017)

Health care providers underestimate symptom intensities of cancer patients: A multicenter European study
por: Laugsand, Eivor A, et al.
Publicado: (2010)

Using Process Indicators to Monitor Documentation of Patient-Centred Variables in an Integrated Oncology and Palliative Care Pathway—Results from a Cluster Randomized Trial
por: Hjermstad, Marianne Jensen, et al.
Publicado: (2021)

Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl
por: Barratt, Daniel T., et al.
Publicado: (2015)

Symptoms in the general Norwegian adult population - prevalence and associated factors
por: Krogstad, Hilde, et al.
Publicado: (2020)

Preparation, Characterization and in vivo Evaluation of Parenteral Sustained Release Microsphere Formulation of Zopiclone
por: Swapna, N, et al.
Publicado: (2010)

Genetic variation in the Catechol-O-Methyltransferase (COMT) gene and morphine requirements in cancer patients with pain
por: Rakvåg, Trude T, et al.
Publicado: (2008)

Genetic variation and cognitive dysfunction in opioid‐treated patients with cancer
por: Kurita, Geana Paula, et al.
Publicado: (2016)

PALLiON – PALLiative care Integrated in ONcology: study protocol for a Norwegian national cluster-randomized control trial with a complex intervention of early integration of palliative care
por: Hjermstad, Marianne Jensen, et al.
Publicado: (2020)

Implementing a Standardized Care Pathway Integrating Oncology, Palliative Care and Community Care in a Rural Region of Mid-Norway
por: Brenne, Anne-Tove, et al.
Publicado: (2021)

Quality of life and symptom intensity over time in people with cancer receiving palliative care: Results from the international European Palliative Care Cancer Symptom study
por: Verkissen, Mariëtte N., et al.
Publicado: (2019)

Is there a genetic cause for cancer cachexia? – a clinical validation study in 1797 patients
por: Solheim, T S, et al.
Publicado: (2011)

Efficacy of Polygonatum sibiricum on Mild Insomnia: A Randomized Placebo-Controlled Trial
por: Ha, Eunji, et al.
Publicado: (2019)

Predictors and trajectory of performance status in patients with advanced cancer: A secondary data analysis of the international European Palliative Care Cancer Symptom study
por: Boland, Jason W, et al.
Publicado: (2018)

Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study
por: Klepstad, Pål, et al.
Publicado: (2004)

Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients
por: Andreassen, Trine Naalsund, et al.
Publicado: (2010)

Surgery for brain metastases—impact of the extent of resection
por: Winther, Rebecca Rootwelt, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_akm7v5557mtjfb4i0q2mhk4fvg